Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Segall

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|February 10, 2012
Multi-parameter optimization: identifying high quality compounds with a balance of propertiesMatthew D Segall
Journal of Chemical Information and Modeling|May 4, 2010
Gaussian processes for classification: QSAR modeling of ADMET and target activityOlga Obrezanova, Matthew D Segall
Drug Discovery Today|January 24, 2014
Addressing toxicity risk when designing and selecting compounds in early drug discoveryMatthew D Segall, Chris Barber
Drug Discovery Today|March 6, 2013
Considering the impact drug-like properties have on the chance of successIskander Yusof, Matthew D Segall
Drug Discovery Today|June 18, 2010
Overcoming psychological barriers to good discovery decisionsAndrew T Chadwick, Matthew D Segall
Journal of Computer-Aided Molecular Design|July 2, 2015
The challenges of making decisions using uncertain dataMatthew D Segall, Edmund J Champness
Drug Discovery Today|June 6, 2002
Predicting ADME properties in silico: methods and modelsDarko Butina, Matthew D Segall, Katrina Frankcombe
Journal of Medicinal Chemistry|February 23, 2016
Avoiding Missed Opportunities by Analyzing the Sensitivity of Our DecisionsMatthew D Segall, Iskander Yusof, Edmund J Champness
Journal of Chemical Theory and Computation|December 18, 2023
Transferable Machine Learning Interatomic Potential for Bond Dissociation Energy Prediction of Drug-like MoleculesElena Gelžinytė, Mario Öeren, Matthew D Segall, et al.
Future Medicinal Chemistry|March 22, 2014
Alternative variables in drug discovery: promises and challengesCele Abad-Zapatero, Edmund J Champness, Matthew D Segall
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|February 10, 2012
Multi-parameter optimization: identifying high quality compounds with a balance of propertiesMatthew D Segall
Journal of Chemical Information and Modeling|May 4, 2010
Gaussian processes for classification: QSAR modeling of ADMET and target activityOlga Obrezanova, Matthew D Segall
Drug Discovery Today|January 24, 2014
Addressing toxicity risk when designing and selecting compounds in early drug discoveryMatthew D Segall, Chris Barber
Drug Discovery Today|March 6, 2013
Considering the impact drug-like properties have on the chance of successIskander Yusof, Matthew D Segall
Drug Discovery Today|June 18, 2010
Overcoming psychological barriers to good discovery decisionsAndrew T Chadwick, Matthew D Segall
Journal of Computer-Aided Molecular Design|July 2, 2015
The challenges of making decisions using uncertain dataMatthew D Segall, Edmund J Champness
Drug Discovery Today|June 6, 2002
Predicting ADME properties in silico: methods and modelsDarko Butina, Matthew D Segall, Katrina Frankcombe
Journal of Medicinal Chemistry|February 23, 2016
Avoiding Missed Opportunities by Analyzing the Sensitivity of Our DecisionsMatthew D Segall, Iskander Yusof, Edmund J Champness
Journal of Chemical Theory and Computation|December 18, 2023
Transferable Machine Learning Interatomic Potential for Bond Dissociation Energy Prediction of Drug-like MoleculesElena Gelžinytė, Mario Öeren, Matthew D Segall, et al.
Future Medicinal Chemistry|March 22, 2014
Alternative variables in drug discovery: promises and challengesCele Abad-Zapatero, Edmund J Champness, Matthew D Segall
Pageof 3